CGM Versus OGTT in Early-Stage Type 1 Diabetes: Comparative Predictive Accuracy and Clinical Implications
Posted inClinical Updates Diabetes & Endocrinology news

CGM Versus OGTT in Early-Stage Type 1 Diabetes: Comparative Predictive Accuracy and Clinical Implications

This review synthesizes evidence demonstrating that continuous glucose monitoring (CGM) metrics, particularly time above 140 mg/dL, predict progression to stage 3 type 1 diabetes with accuracy comparable to oral glucose tolerance test (OGTT), offering a practical tool for early disease monitoring.
Intravitreal Bevacizumab versus Laser Therapy in Retinopathy of Prematurity: Analyzing Retreatment Rates, Timing, and Risk Predictors
Posted innews Ophthalmology Pediatrics

Intravitreal Bevacizumab versus Laser Therapy in Retinopathy of Prematurity: Analyzing Retreatment Rates, Timing, and Risk Predictors

This study compares retreatment rates and timing in retinopathy of prematurity among infants treated with intravitreal bevacizumab versus laser therapy, highlighting lower early retreatment rates and delayed intervention in the bevacizumab group, especially in high-risk premature infants.